Immunoglobulins and complement factor C4 in adult rhinosinusitis

Clinical and Experimental Immunology

Volumn 145, Issue 2, 2006, Pages 219-227

  Seppanen M ^a   Suvilehto, J ^a   Lokki, M L ^b   Notkola, I L ^c   Jarvinen A ^a   Jarva, H ^d   Seppala I ^d   Tahkokallio, O ^e   Malmberg, H ^a   Meri, S ^d   Valtonen, V ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e JORVI HOSPITAL   (Finland)

Author keywords

Complement; Disease susceptibility; Immunoglobulins; MHC HLA; Mucosal immunity; Polymorphisms; Resistance

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C4B; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4;

ACUTE DISEASE; ADULT; AGED; ARTICLE; ASTHMA; CHRONIC DISEASE; COMPARATIVE STUDY; COMPLEMENT BLOOD LEVEL; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT DEFICIENCY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HEMOLYSIS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL PARAMETERS; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NOSE POLYP; NULL ALLELE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RHINOSINUSITIS; RISK ASSESSMENT; RISK FACTOR; UPREGULATION;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; COMPLEMENT C3; COMPLEMENT C4; COMPLEMENT HEMOLYTIC ACTIVITY ASSAY; DISEASE SUSCEPTIBILITY; FEMALE; GENE DELETION; GENOTYPE; HUMANS; IMMUNOGLOBULINS; IMMUNOPHENOTYPING; LOGISTIC MODELS; MALE; MIDDLE AGED; RECURRENCE; SINUSITIS;

EID: 33745938788     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03134.x     Document Type: Article

References (54)

1. Shashy RG, Moore EJ, Weaver A. Prevalence of the chronic sinusitis diagnosis in Olmsted County. Minnesota. Arch Otolaryngol Head Neck Surg 2004; 130:320-3.
2. Cherry DK, Woodwell DA. National ambulatory medical care survey: 2000 summary. Adv Data 2002; 328:1-32.
3. Lawton AR. IgG subclass deficiency and the day-care generation. Pediatr Infect Dis J 1999; 18:462-6.
4. Buckley RH. Immunoglobulin G subclass deficiency: fact or fancy? Curr Allergy Asthma Rep 2002; 2:356-60.
5. May A, Zielen S, von Ilberg C, Weber A. Immunoglobulin deficiency and determination of pneumococcal antibody titers in patients with therapy-refractory recurrent rhinosinusitis. Eur Arch Otorhinolaryngol 1999; 256:445-9.
6. Edwards E, Razvi S, Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to pneumococcal vaccine. Clin Immunol 2004; 111:93-7.
7. Lacombe C, Aucouturier P, Preud'homme JL. Selective IgG1 deficiency. Clin Immunol Immunopathol 1997; 84:194-201.
8. Pan Q, Hammarstrom L. Molecular basis of IgG subclass deficiency. Immunol Rev 2000; 178:99-110.
9. Larsen CE, Alper CA. The genetics of HLA-associated disease. Curr Opin Immunol 2004; 16:660-7.
10. Lund VJ, Scadding GK. Immunologic aspects of chronic sinusitis. J Otolaryngol 1991; 20:379-81.
11. Scadding GK, Lund VJ, Darby YC, Navas-Romero J, Seymour N, Turner MW. IgG subclass levels in chronic rhinosinusitis. Rhinology 1994; 32:15-9.
12. Armenaka M, Grizzanti J, Rosenstreich DL. Serum immunoglobulins and IgG subclass levels in adults with chronic sinusitis: evidence for decreased IgG3 levels. Ann Allergy 1994; 72:507-14.
13. Sethi DS, Winkelstein JA, Lederman H, Loury MC. Immunologic defects in patients with chronic recurrent sinusitis: diagnosis and management. Otolaryngol Head Neck Surg 1995; 112:242-7.
14. Hoover GE, Newman LJ, Platts-Mills TA, Phillips CD, Gross CW, Wheatley LM. Chronic sinusitis: risk factors for extensive disease. J Allergy Clin Immunol 1997; 100:185-91.
15. Tahkokallio O, Seppala IJ, Sarvas H, Kayhty H, Mattila PS. Concentrations of serum immunoglobulins and antibodies to pneumococcal capsular polysaccharides in patients with recurrent or chronic sinusitis. Ann Otol Rhinol Laryngol 2001; 110:675-81.
16. Chee L, Graham SM, Carothers DG, Ballas ZK. Immune dysfunction in refractory sinusitis in a tertiary care setting. Laryngoscope 2001; 111:233-5.
17. Walport MJ. Complement. First of two parts. N Engl J Med 2001; 344:1058-66.
18. Carroll MC. The complement system in regulation of adaptive immunity. Nat Immunol 2004; 5:981-6.
19. Jonsson G, Truedsson L, Sturfelt G, Oxelius VA, Braconier JH, Sjoholm AG. Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease. Medicine (Balt) 2005; 84:23-34.
20. Alper CA, Marcus-Bagley D, Awdeh Z et al. Prospective analysis suggests susceptibility genes for deficiencies of IgA and several other immunoglobulins on the [HLA-B8, SC01, DR3] conserved extended haplotype. Tissue Antigens 2000; 56:207-16.
21. Blanchong CA, Chung EK, Rupert KL et al. Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, slp and C4. Int Immunopharmacol 2001; 1:365-92.
22. Zwart B, Ciurana C, Rensink I, Manoe R, Hack CE, Aarden LA. Complement activation by apoptotic cells occurs predominantly via IgM and is limited to late apoptotic (secondary necrotic) cells. Autoimmunity 2004; 37:95-102.
23. Rittner C, Meier EM, Stradmann B et al. Partial C4 deficiency in subacute sclerosing panencephalitis. Immunogenetics 1984; 20:407-15.
24. Rowe PC, McLean RH, Wood RA, Leggiadro RJ, Winkelstein JA. Association of homozygous C4B deficiency with bacterial meningitis. J Infect Dis 1989; 160:448-51.
25. Bishof NA, Welch TR, Beischel LS. C4B deficiency: a risk factor for bacteremia with encapsulated organisms. J Infect Dis 1990; 162:248-50.
26. Fasano MB, Densen P, McLean RH, Winkelstein JA. Prevalence of homozygous C4B deficiency in patients with deficiencies of terminal complement components and meningococcemia. J Infect Dis 1990; 162:1220-1.
27. Cates KL, Densen P, Lockman JC, Levine RP. C4B deficiency is not associated with meningitis or bacteremia with encapsulated bacteria. J Infect Dis 1992; 165:942-4.
28. Hentges F, Hoffmann A, Oliveira de Araujo F, Hemmer R. Prolonged clinically asymptomatic evolution after HIV-1 infection is marked by the absence of complement C4 null alleles at the MHC. Clin Exp Immunol 1992; 88:237-42.
29. Pasta L, Pietrosi G, Marrone C et al. C4BQ0: a genetic marker of familial HCV-related liver cirrhosis. Dig Liver Dis 2004; 36:471-7.
30. Laitinen T, Lokki ML, Tulppala M, Ylikorkala O, Koskimies S. Tumour necrosis factor B gene polymorphism in relation to complotype in couples with spontaneous abortions and in control families. Scand J Immunol 1992; 35:131-5.
31. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 1997; 117:S1-7.
32. Lutz HU, Stammler P, Bianchi V et al. Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level. Blood 2004; 103:465-72.
33. Marcus D, Alper CA. Methods for allotyping complement proteins. In: Rose NR, Friedman H, Fahey JL, eds. Manual of clinical laboratory immunology, 3rd edn. Washington, DC: American Society for Microbiology, 1996:185-96.
34. Barba GM, Braun-Heimer L, Rittner C, Schneider PM. A new PCR-based typing of the rodgers and chido antigenic determinants of the fourth component of human complement. Eur J Immunogenet 1994; 21:325-39.
35. Lund VJ, Mackay IS. Staging in rhinosinusitus. Rhinology 1993; 31:183-4.
36. Anand VK, Osguthorpe JD, Rice D. Surgical management of adult rhinosinusitis. Otolaryngol Head Neck Surg 1997; 117:S50-2.
37. Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 2001; 86:494-507.
38. Notarangelo L, Casanova JL, Fischer A et al. Primary immunodeficiency diseases: an update. J Allergy Clin Immunol 2004; 114:677-87.
39. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40:1725.
40. Meltzer EO, Hamilos DL, Hadley JA et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004; 114:5155-212.
41. Schauer U, Stemberg F, Rieger CH et al. IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with the binding site reagents. Clin Chem 2003; 49:1924-9.
42. Bird P, Lachmann PJ. The regulation of IgG subclass production in man: low serum IgG4 in inherited deficiencies of the classical pathway of C3 activation. Eur J Immunol 1988; 18:1217-22.
43. Gual L, Martinez A, Fernandez-Arquero M et al. Major histocompatibility complex haplotypes in Spanish immunoglobulin A deficiency patients: a comparative fine mapping microsatellite study. Tissue Antigens 2004; 64:671-7.
44. Alper CA, Xu J, Cosmopoulos K et al. Immunoglobulin deficiencies and susceptibility to infection among homozygotes and heterozygotes for C2 deficiency. J Clin Immunol 2003; 23:297-305.
45. Aalberse RC, Schuurman J. IgG4 breaking the rules. Immunology 2002; 105:9-19.
46. Jarva H, Jokiranta TS, Wurzner R, Meri S. Complement resistance mechanisms of streptococci. Mol Immunol 2003; 40:95-107.
47. Nordstrom T, Blom AM, Forsgren A, Riesbeck K. The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surrace proteins A1 and A2. J Immunol 2004; 173:4598-606.
48. Cunningham-Rundles C. Physiology of IgA and IgA deficiency. J Clin Immunol 2001; 21:303-9.
49. Basta M, Van Goor F, Luccioli S et al. F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins. Nat Med 2003; 9:431-8.
50. Chung EK, Yang Y, Rennebohm RM et al. Genetic sophistication of human complement components C4A and C4B and RP-C4-CYP21-TNX (RCCX) modules in the major histocompatibility complex. Am J Hum Genet 2002; 71:823-37.
51. Yang Y, Chung EK, Zhou B et al. Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities, and body mass index. J Immunol 2003; 171:2734-45.
52. Schubert MS, Hutcheson PS, Graff RJ, Santiago L, Slavin RG. HLA-DQB1 *03 in allergic fungal sinusitis and other chronic hypertrophic rhinosinusitis disorders. J Allergy Clin Immunol 2004; 114:1376-83.
53. Sanclement JA, Webster P, Thomas J, Ramadan HH. Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope 2005; 115:578-82.
54. Test ST, Mitsuyoshi J, Connolly CC, Lucas AH. Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide. Infect Immun 2001; 69:3031-40.